ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : University/Organization : University of Pennsylvania Cancer Center

Include trials that are no longer recruiting patients.

11 studies were found.
1.RecruitingBortezomib in Treating Patients With Advanced Non-small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
2.RecruitingCombination Chemotherapy Followed By Tipifarnib Plus Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
Conditions: stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer
3.RecruitingEF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal Cancer
Conditions: Endocrine Cancer; female reproductive cancer; Gastrointestinal Cancer; musculoskeletal cancer; unclassified and other cancer
4.RecruitingEF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural Cancer
Conditions: malignant ascites; peritoneal cavity cancer; advanced malignant mesothelioma; localized malignant mesothelioma; recurrent malignant mesothelioma
5.RecruitingEF5 in Treating Patients With Solid Tumors
Condition: unspecified adult solid tumor, protocol specific
6.RecruitingImatinib Mesylate and Bevacizumab in Treating Patients With Advanced Melanoma or Other Advanced Cancers
Conditions: stage III melanoma; Stage IV Melanoma; Recurrent Melanoma; unspecified adult solid tumor, protocol specific
7.RecruitingInterleukin-12 and Interleukin-2 in Treating Patients With Mycosis Fungoides
Conditions: Cutaneous T-Cell Lymphoma; mycosis fungoides and Sezary syndrome
8.RecruitingIntrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions
Condition: Cancer
9.RecruitingPhotodynamic Therapy With Lutetium Texaphyrin in Treating Patients With Locally Recurrent Prostate Cancer
Conditions: adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; recurrent prostate cancer
10.RecruitingTipifarnib and Radiation Therapy in Treating Patients With Unresectable Locally Advanced Pancreatic Cancer
Conditions: stage II pancreatic cancer; stage III pancreatic cancer; recurrent pancreatic cancer
11.RecruitingVaccine Plus Montanide ISA-51 and Sargramostim in Treating Patients With Stage IV Breast Cancer
Conditions: recurrent breast cancer; stage IV breast cancer

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act